187 related articles for article (PubMed ID: 1835898)
1. Central ANP attenuates pressor responses to central AVP in WKY and SHR.
Stepniakowski K; Budzikowski A; Lon S; Szczepanska-Sadowska E
Brain Res Bull; 1991 Aug; 27(2):247-9. PubMed ID: 1835898
[TBL] [Abstract][Full Text] [Related]
2. Effect of vasopressin and V1 receptors blockade on hypotensive action of ANP in normotensive (WKY) and spontaneously hypertensive rats.
Lapiński M; Stepniakowski K; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E
J Physiol Pharmacol; 1992 Mar; 43(1):65-78. PubMed ID: 1450435
[TBL] [Abstract][Full Text] [Related]
3. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats.
Stepniakowski K; Budzikowski A; Loń S; Szczepańska-Sadowska E
J Auton Nerv Syst; 1994 Apr; 47(1-2):33-43. PubMed ID: 8188982
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor enhances vasopressin-induced bradycardia in normotensive (WKY) but not in spontaneously hypertensive (SHR) rats.
Lapiński M; Stepniakowski K; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E
Eur J Clin Invest; 1988 Dec; 18(6):568-74. PubMed ID: 2975994
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial N(G)-nitro-L-arginine.
Paczwa P; Budzikowski AS; Szczepańska-Sadowska E
Brain Res; 1997 Feb; 748(1-2):51-61. PubMed ID: 9067444
[TBL] [Abstract][Full Text] [Related]
6. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR.
Budzikowski AS; Paczwa P; Szczepańska-Sadowska E
Am J Physiol; 1996 Sep; 271(3 Pt 2):H1057-64. PubMed ID: 8853341
[TBL] [Abstract][Full Text] [Related]
7. Effect of NG-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
Styś T; Szczepańska-Sadowska E
J Physiol Pharmacol; 1994 Jun; 45(2):231-40. PubMed ID: 7949233
[TBL] [Abstract][Full Text] [Related]
8. Pressor responsiveness to vasopressin in spontaneously hypertensive rats.
Stepniakowski K; Lapiński M; Januszewicz A; Noszczyk B; Szczepańska-Sadowska E
Acta Physiol Pol; 1989; 40(2):171-82. PubMed ID: 2641416
[TBL] [Abstract][Full Text] [Related]
9. [Effects of human atrial natriuretic factor-(99-126) on plasma and brain vasopressin in stroke-prone spontaneously hypertensive rats].
Sun SD; Zhang Q; Zhao XW; Tang J
Sheng Li Xue Bao; 1989 Feb; 41(1):56-62. PubMed ID: 2527409
[TBL] [Abstract][Full Text] [Related]
10. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K
Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the effect of endothelin-3 on blood pressure by atrial natriuretic peptide in conscious spontaneously hypertensive (SHR) and normotensive (WKY) rats.
Januszewicz A; Stys A; Stys T; Lapinski M; Lon S
Blood Press; 1993 Jun; 2(2):146-54. PubMed ID: 8180728
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor-induced vasodepression occurs through central nervous system.
Levin ER; Weber MA; Mills S
Am J Physiol; 1988 Sep; 255(3 Pt 2):H616-22. PubMed ID: 2970804
[TBL] [Abstract][Full Text] [Related]
13. Clonidine fails to reduce pressor responsiveness of conscious spontaneously hypertensive rats to vasopressin.
Datar S; Laverty WH; McNeill JR
Can J Physiol Pharmacol; 1986 Mar; 64(3):284-9. PubMed ID: 3708435
[TBL] [Abstract][Full Text] [Related]
14. A comparison of synthetic human and rat ANP administered intracerebroventricularly in freely moving normotensive and hypertensive rats.
Squadrito F; Frisina N; Buemi M; Sturniolo R; Autolitano A; Magri V; Squadrito G; Caputi AP
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S27-30. PubMed ID: 2473344
[TBL] [Abstract][Full Text] [Related]
15. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.
Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J
Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410
[TBL] [Abstract][Full Text] [Related]
16. The role of GABA in the central regulation of AVP and ANP release and blood pressure due to angiotensin and carbachol, and central GABA release due to blood pressure changes.
Kimura T; Funyu T; Ohta M; Yamamoto T; Ota K; Shoji M; Inoue M; Sato K; Abe K
J Auton Nerv Syst; 1994 Dec; 50(1):21-9. PubMed ID: 7844311
[TBL] [Abstract][Full Text] [Related]
17. Augmented central pressor action of magnesium in SHR.
Oda S; Seto S; Akahoshi M; Nagao S; Ozeki S; Kusano S; Yano K; Hashiba K
Am J Med Sci; 1993 Oct; 306(4):218-24. PubMed ID: 8213889
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive rats.
Sampey DB; Burrell LM; Widdop RE
Am J Physiol; 1999 Mar; 276(3):R872-9. PubMed ID: 10070150
[TBL] [Abstract][Full Text] [Related]
19. Interaction of vasopressin and of the atrial natriuretic peptide in blood pressure control.
Szczepanska-Sadowska E
Acta Physiol Scand Suppl; 1989; 583():79-87. PubMed ID: 2530757
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 in hypertension in the baroreflex-intact SHR: a role independent from vasopressin release.
Rossi NF; O'Leary DS; Woodbury D; Chen H
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E18-24. PubMed ID: 10893318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
